previous compound ID: 140 next compound
InChIKey: AJLFOPYRIVGYMJ-INTXDZFKSA-N
SMILES: CC[C@H](C)C(=O)O[C@H]1CCC=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"GW Carlile" "B Kus" "J Liao" "E Matthes" "DY Thomas" "JW Hanrahan" "D Rotin" "J Goepp" "R Robert" "SD Macknight"

chemical graph of compound 140





CID is 64715
synonyms found at PubChem are:
Mevastatin, compactin, 73573-88-3, ML-236B, Mevastatinum, Mevastatina, Mevastatine, Mevastatinum [INN-Latin], Antibiotic ML 236B, Mevastatin [INN], CS 500, Compactin (penicillium), Mevastatine [INN-French], UNII-1UQM1K0W9X, Mevastatina [INN-Spanish], ML 236 B, CCRIS 4505, 1UQM1K0W9X, CHEMBL54440, CHEBI:34848, [(1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate, Mevastatin (Compactin), ML236B, 7-(1,2,6,7,8,8a-Hexahydro-2-methyl-8-(2-methylbutyryloxy)naphthyl)-3-hydroxyheptan-5-olide, 6-demethylmevinolin, (1S,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-7-methyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthyl (S)-2-methylbutyrate, (S)-((1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) 2-methylbutanoate, Butanoic acid, 2-methyl-, (1S,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-7-methyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S)-, Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-7-methyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1-alpha(R*),7-beta,8-beta(2S*,4S*),8a-beta))-, SMR000336944, kompaktin, Mevastatin,, ML 236B, NCGC00095942-01, AC1Q5WYM, D0J9GD, EC 700-442-0, AC1L21SK, SCHEMBL1116, DSSTox_CID_20684, DSSTox_RID_79540, DSSTox_GSID_40684, Lopac0_000754, MLS000721804, MLS000759452, MLS001424284, MLS002207227, GTPL3031, DTXSID4040684, Mevastatin, >=96% (HPLC), CTK8B3049, AJLFOPYRIVGYMJ-INTXDZFKSA-N, MolPort-002-885-840, MolPort-003-849-214, HMS2052P07, HMS2089D10, HMS2232N09, HMS3262G10, HMS3268A19, HMS3713B06, 2-Methyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester(compactin), 58948-09-7, Butanoic acid, 2-methyl-, (1S,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-7-methyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (2S)-, KS-00000XT7, ZINC3833876, Tox21_111540, Tox21_500754, ANW-41687, BDBM50011036, BG0377, CS-500, MFCD05662341, s4223, AKOS015994712, Mevastatin, >=95% (HPLC), powder, CCG-101174, CS-1234, DB06693, KS-1085, LP00754, NC00424, SMP1_000077, NCGC00025202-04, NCGC00261439-01, (1S,7S,8S,8aR)-8-(2-((2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl(2S)-2-methylbutanoate, CPD000336944, HY-17408, I518, LS-46360, SAM001246644, SC-11548, AB0013739, CAS-73573-88-3, TR-023864, B1788, EU-0100754, M2275, C13963, M 2537, W-5323, AB00588266-06, AB00588266-08, AB00588266_09, 573M883, SR-01000729493, L-637312, SR-01000729493-4, BRD-K94441233-001-03-1, BRD-K94441233-001-17-1, Compactin, 6-Demethylvevinolin, CS-500, ML-236 B, (1S,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate, (S)-((1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) 2-methylbutanoate, (S)-2-Methyl-butyric acid (1S,7S,8S,8aR)-8-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester, 2-Methyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester, 2-Methyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester((+)-compactin), 60478-65-1